Hinge Health Chair Gabriel Mecklenburg Sells $14M in Stock

Hinge Health Executive Chairman Gabriel Mecklenburg sold 150,000 shares of company stock valued at $13.98 million, reducing his direct position by half as shares traded near their 52-week high.

According to an SEC Form 4 filing, the transaction took place on September 14, 2026, at an average price of $93.22 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan, leaving Mecklenburg with a direct holding of 150,000 shares valued at approximately $13.98 million.

Market Performance and Valuation

The insider transaction coincided with active trading for Hinge Health Inc. (NYSE: HNGE). Following the sale, the stock closed at $94.90, marking a 0.19% increase from the previous session.

Over the past year, Hinge Health shares have experienced upward momentum. Market data shows the stock's 52-week trading range spans from a low of $30.08 to a high of $96.66, placing Mecklenburg's execution near the upper bound of the company's historical valuation.

How Rule 10b5-1 Plans Function

Corporate insiders frequently utilize Rule 10b5-1 trading plans to sell company stock without running afoul of insider trading regulations. Established under the Securities Exchange Act of 1934, these plans allow directors and executives to set a predetermined schedule for buying or selling a specific number of shares at a future date.

By establishing the plan during a period when they do not possess material non-public information, insiders can execute transactions automatically even if they subsequently acquire sensitive corporate data. This legal framework provides an affirmative defense against allegations of insider trading, offering transparency to public markets regarding planned liquidity events by top leadership.